E3024 is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes

被引：0
|
作者：
Yasuda, Nobuyuki
Nagakura, Tadashi
Inoue, Takashi
Yamazaki, Kazuto
Katsutani, Naruo
Takenaka, Osamu
Clark, Richard
Matsuura, Fumiyoshi
Emori, Eita
Yoshikawa, Seiji
Kira, Kazunobu
Okada, Toshimi
Ikuta, Hironori
Saeki, Takao
Asano, Osamu
Tanaka, Isao
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A349 / A349
页数：1
相关论文
共 50 条
  • [31] Incretin mimetics and dipeptidyl peptidase-IV inhibitors: A review of emerging therapies for type 2 diabetes
    Kendall, David M.
    Kim, Dennis
    Maggs, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2006, 8 (03) : 385 - 396
  • [32] Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes
    Gupta, Rajesh
    Walunj, Sameer S.
    Tokala, Ranjeet K.
    Parsa, Kishore V. L.
    Singh, Santosh Kumar
    Pal, Manojit
    CURRENT DRUG TARGETS, 2009, 10 (01) : 71 - 87
  • [33] Alogliptin benzoate.: Dipeptidyl-peptidase IV (DPP IV) inhibitor, treatment of type 2 diabetes
    Wang, Y.
    Serradell, N.
    Rosa, E.
    Bolos, J.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 7 - 12
  • [34] Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes
    Holst, JJ
    Deacon, CF
    DIABETES, 1998, 47 (11) : 1663 - 1670
  • [35] Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes
    Tan, Xueying
    Hu, Jingbo
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1285 - 1293
  • [36] Dipeptidyl peptidase IV (DPP-IV) inhibition as a treatment for type 2 diabetes
    Thornberry, N.
    FEBS JOURNAL, 2009, 276 : 77 - 77
  • [37] Dipeptidyl peptidase IV (DP-IV) inhibition as a treatment for Type 2 diabetes
    Thornberry, N
    FASEB JOURNAL, 2004, 18 (08): : C120 - C120
  • [38] Dipeptidyl peptidase IV (DPP-IV) inhibition as a treatment for Type 2 diabetes
    Thornberry, NA
    FASEB JOURNAL, 2005, 19 (05): : A1723 - A1723
  • [39] Incretin mimetics and dipeptidyl peptidase-IV inhibitors: Potential new therapies for type 2 diabetes mellitus
    Triplitt, C
    Wright, A
    Chiquette, E
    PHARMACOTHERAPY, 2006, 26 (03): : 360 - 374
  • [40] Vildagliptin.: Agent for type 2 diabetes, dipeptidyl-peptidase IV inhibitor
    McIntyre, JA
    Castañer, J
    DRUGS OF THE FUTURE, 2004, 29 (09) : 887 - 891
12345